Lehrstuhl für Innere Medizin III

CAR-T CELL TREATMENT OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS- SAFETY AND PRELIMINARY EFFICACY DATA FROM THE FIRST FOUR PATIENTS (2022) Schett G, Böltz S, Müller F, Kleyer A, Völkl S, Aigner M, Gary R, et al. Conference contribution SUBJECTIVE ASSESSMENT OF PHYSICAL FUNCTION DOES NOT SUFFICIENTLY EXPLAIN VARIANCE OF MEASURED HAND FUNCTION AND GRIP STRENGTH IN ARTHRITIS PATIENTS AND NON-ARTHRITIS CONTROLS (2022) Liphardt AM, Tascilar K, Coppers B, Manger E, Liehr S, Bieniek LM, Bayat S, et al. Conference contribution FIBROBLAST ACTIVATION PROTEIN (FAP) PET-CT IMAGING ALLOWS TO DEPICT INFLAMMATORY JOINT REMODELING IN PATIENTS WITH PSORIATIC ARTHRITIS (2022) Schmidkonz C, Rauber S, Raimondo MG, Labinsky H, Atzinger A, Treutlein C, Knitza J, et al. Conference contribution THE NUCLEAR RECEPTOR TR4 ORCHESTRATES CYTOSKELETAL ORGANIZATION IN A G alpha 12/ROCK-DEPENDENT MANNER TO PROMOTE MYOFIBROBLAST DIFFERENTIATION AND TISSUE FIBROSIS IN SYSTEMIC SCLEROSIS (2022) Shen L, Zhang Y, Honglin Z, Distler J Conference contribution DEREGULATION OF TFAM EXPRESSION PROMOTES MITOCHONDRIAL DAMAGE AND FIBROBLAST ACTIVATION IN SYSTEMIC SCLEROSIS (2022) Zhou X, Trinh MT, TRAN MANH C, Giessl A, Bergmann C, Györfi AH, Schett G, Distler J Conference contribution L-ARGININE REPROGRAMS OSTEOCLAST PURINE METABOLISM AMELIORATING BONE LOSS IN RHEUMATOID ARTHRITIS (2022) Cao S, Song R, Meng X, Kachler K, Fuchs M, Meng X, Li Y, et al. Conference contribution BASELINE CLINICAL DISEASE ACTIVITY IS NOT CRITICAL FOR PREDICTING REMISSION OF ADULTS ONSET STILL'S DISEASE (2022) Groetsch J, Tascilar K, Schett G, Foell D, Rech J Conference contribution A MINIMAL-INVASIVE METHOD TO RETRIEVE AND IDENTIFY ENTHESEAL TISSUE FROM PSORIATIC ARTHRITIS PATIENTS (2022) Raimondo MG, Pachowsky M, Xu C, Rauber S, Tascilar K, Labinsky H, Soare A, et al. Conference contribution BARICITINIB LEADS TO RAPID AND PERSISTENT RESOLUTION OF SYNOVITIS AS MEASURED BY HAND MRI IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) FAILING CS/BDMARD THERAPY (2022) Kemenes S, Bayat S, Simon D, Krönke G, Bohr D, Valor L, Hartmann F, et al. Conference contribution SIMILAR EFFICACY AND DRUG SURVIVAL RATES OF BARICITINIB MONOTHERAPY AND BARICITINIB/METHOTREXATE COMBINATION THERAPY IN REAL-LIFE TREATMENT OF RHEUMATOID ARTHRITIS - RESULTS FROM A PROSPECTIVE COHORT OF BARICITINIB-TREATED PATIENTS (2022) Bayat S, Tascilar K, Bohr D, Simon D, Kronke G, Hartmann F, Knitza J, et al. Conference contribution, Abstract of a poster